[
    [
        {
            "time": "",
            "original_text": "平安证券维持泰格医药推荐评级：临床试验陆续恢复，收入逐季改善",
            "features": {
                "keywords": [
                    "平安证券",
                    "泰格医药",
                    "推荐评级",
                    "临床试验",
                    "恢复",
                    "收入",
                    "逐季改善"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券维持泰格医药推荐评级：临床试验陆续恢复，收入逐季改善",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]